Planta Medica · 2007 · 37 citations · 0 references
PharmacyBotanyPharmacologyDrug DiscoveryPlant BiochemistryStructure-activity RelationshipsMedicinal PlantsMolecular DockingNatural Product Drug DiscoveryProtein-ligand DockingProtein-ligand RecognitionVirtual ScreeningBioactive ConstituentsConcentrationHerbal Drug DiscoveryInverse DockingNegative ControlsPharmacological ProfilingPharmacological ScreeningPlant Protein Profiling
Reverse pharmacognosy aims at finding biological targets for natural compounds by virtual or real screening and identifying natural resources that contain the active molecules. We report herein a study focused on the identification of biological properties of meranzin, a major component isolated from Limnocitrus littoralis (Miq.) Swingle. Selnergy, an IN SILICO biological profiling software, was used to identify putative binding targets of meranzin. Among the 400 screened proteins, 3 targets were selected: COX1, COX2 and PPARgamma. Binding tests were realised for these 3 protein candidates, as well as two negative controls. The predictions made by Selnergy were consistent with the experimental results, meaning that these 3 targets can be modulated by an extract containing this compound in a suitable concentration. These results demonstrate that reverse pharmacognosy and its inverse docking component is a powerful tool to identify biological properties for natural molecules and hence for plants containing these compounds.